CDC Acting Director Delayed Vaccine-Effectiveness Paper Over Methodology Concerns

1 min read
Source: AOL.com
CDC Acting Director Delayed Vaccine-Effectiveness Paper Over Methodology Concerns
Photo: AOL.com
TL;DR Summary

The CDC’s acting director, Dr. Jay Bhattacharya, reportedly delayed the release of an MMWR study showing Covid vaccines reduce severe illness, citing concerns about the observational method; the paper, based on a test‑negative design, was expected to indicate about a 50% reduction in severe outcomes among adults with the 2025‑26 vaccine formulation. Officials say leadership routinely reviews papers for methodological issues, while critics within and around the Trump administration have framed vaccine research debates as political interference. If the MMWR paper isn’t published, the authors could submit the findings to a medical journal after further analysis.

Share this article

Reading Insights

Total Reads

0

Unique Readers

7

Time Saved

264 min

vs 265 min read

Condensed

100%

52,96796 words

Want the full story? Read the original article

Read on AOL.com